Cargando…
Radiation and nitroimidazoles in supratentorial high grade gliomas: a second clinical trial.
As a continuation of a previous controlled trial using "high-dose" metronidazole as a specific sensitizer of hypoxic cells, we used a more efficient nitroimidazole derivative (misonidazole, MISO) in combination with higher doses of radiation in patients with supratentorial high-grade astro...
Autores principales: | Urtasun, R., Feldstein, M. L., Partington, J., Tanasichuk, H., Miller, J. D., Russell, D. B., Agboola, O., Mielke, B. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1982
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2011055/ https://www.ncbi.nlm.nih.gov/pubmed/6285947 |
Ejemplares similares
-
Anomalous patterns of nitroimidazole binding adjacent to necrosis in human glioma xenografts: possible role of decreased oxygen consumption.
por: Parliament, M. B., et al.
Publicado: (1997) -
Postoperative functional status in patients with supratentorial superficial low-grade glioma
por: Zhang, Ji, et al.
Publicado: (2017) -
Second U.K. workshop on the enhancement of chemotherapy by nitroimidazoles
Publicado: (1983) -
Management of supratentorial recurrent low-grade glioma: A multidisciplinary experience in 35 adult patients
por: Spitaels, Julien, et al.
Publicado: (2017) -
The Role of Nitroreductases in Resistance to Nitroimidazoles
por: Thomas, Carol, et al.
Publicado: (2021)